Mixed bacterial infection model of sepsis in rabbits and its application to evaluate superantigen-adsorbing device

Blood Purification

Volumn 23, Issue 2, 2005, Pages 119-127

  Fukuyama, Mayumi ^a   Miwa, Keishi ^a   Shibayama, Naoko ^a   Ogura, Shinji ^b   Nishiyama, Takashi ^c   Maekawa, Nobuhiro ^b  

^a TORAY INDUSTRIES INC   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Adsorption; Animal model; Blood purification; Cecal ligation and puncture; Multiple organ failure; Staphylococcus aureus; Superantigen; Toxic shock syndrome toxin 1

Indexed keywords

POLYSTYRENE; SUPERANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATHETER INFECTION; COMPOSITE MATERIAL; CONTROLLED STUDY; GRAM POSITIVE BACTERIUM; HEMOPERFUSION; MALE; MEAN ARTERIAL PRESSURE; MIXED INFECTION; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SPECIES COMPARISON; STAPHYLOCOCCUS AUREUS; SURVIVAL TIME; TOXIC SHOCK SYNDROME;

ADSORPTION; ANIMALS; BACTERIAL INFECTIONS; BACTERIAL TOXINS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ENTEROTOXINS; HEMOPERFUSION; LIPOPOLYSACCHARIDES; MALE; RABBITS; SEPSIS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 16344394466     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083206     Document Type: Article

References (24)

1. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 1993;328:1471-1477.
2. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Regnier B: Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 1995;274:968-974.
3. Bone RC: Gram-positive organisms and sepsis. Arch Intern Med 1994;154:26-34.
4. Sriskandan S, Cohen J: The pathogenesis of septic shock. J Infect 1995;30:201-206.
5. Ziegler EJ, Fisher CJ Jr, Sprung CL, Straube RC, Sadoff JC, Foulke GE, Wortel CH, Fink MP, Dellinger RP, Teng NN, Allen E, Berger HJ, Knatterud GL, LoBuglio AF, Smith CR: Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med 1991;324:429-436.
6. Levin M, Quint PA, Goldstein B, Barton P, Bradley JS, Shemie SD, Yeh T, Kim SS, Cafaro DP, Scannon PJ, Giroir BP: Recombinant bactericidal/permeability- increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: A randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet 2000;356:961-967.
7. Sriskandan S, Cohen J: Gram-positive sepsis. Mechanisms and differences from gram-negative sepsis. Infect Dis Clin North Am 1999;13:397-412.
8. Parsonnet J, Gillis ZA, Richter AG, Pier GB: A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1: Infect Immun 1987;55:1070-1076.
9. De Boer ML, Kum WW, Chow AW: Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome. Can J Microbiol 1999;45:250-256.
10. Miwa K, Fukuyama M, Kunitomo T, Igarashi H: Rapid assay for detection of toxic shock syndrome toxin 1 from human sera. J Clin Microbiol 1994;32:539-542.
11. Sriskandan S, Moyes D, Cohen J: Detection of circulating bacterial superantigen and lymphotoxin-alpha in patients with streptococcal toxic-shock syndrome. Lancet 1996;348:1315-1316.
12. Nagaki M, Hughes RD, Keane HM, Goka J, Williams R: Clearance and tissue distribution of staphylococcal enterotoxin A in the rat and potential use of adsorbents for removal from plasma. J Med Microbiol 1993;38:354-359.
13. Stegmayr BG: The presence of superantigens and complex host responses in severe sepsis may need a broad therapeutic approach. Ther Apher 2001;5:111-114.
14. Stegmayr BG: Is there a future for adsorption techniques in sepsis? Blood Purif 2000;18:149-155.
15. Miwa K, Fukuyama M, Ida N, Igarashi H, Uchiyama T: Preparation of superantigen-adsorbing device and its superantigen removal efficacies in vitro and in vivo. Int J Infect Dis 2003;7:21-26.
16. Deitch EA: Animal models of sepsis and shock: A review and lessons learned. Shock 1998;9:1-11.
17. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shock: A review of laboratory models and a proposal. J Surg Res 1980;29:189-201.
18. Teramoto K: Chemical modification of polystyrene surfaces by amidomethylation reaction with N-methilol-2-chloroacetamide. Reactive Polymers 1991;15:89-101.
19. Miwa K, Fukuyama M, Sakai R, Shimizu S, Ida N, Endo M, Igarashi H: Sensitive enzyme-linked immunosorbent assays for the detection of bacterial superantigens and antibodies against them in human plasma. Microbiol Immunol 2000;44:519-523.
20. Rietschel ET, Brade H, Holst O, Brade L, Muller-Loennies S, Mamat U, Zahringer U, Beckmann F, Seydel U, Brandenburg K, Ulmer AJ, Mattern T, Heine H, Schletter J, Loppnow H, Schonbeck U, Flad HD, Hauschildt S, Schade UF, Di Padova F, Kusumoto S, Schumann RR: Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol 1996;216:39-81.
21. Tokman MG, Carey KD, Quimby FW: The pathogenesis of experimental toxic shock syndrome: The role of interleukin-2 in the induction of hypotension and release of cytokines. Shock 1995;3:145-151.
22. Luhm J, Kirchner H, Rink L: One-way synergistic effect of low superantigen concentrations on lipopolysaccharide-induced cytokine production. J Interferon Cytokine Res 1997;17:229-238.
23. Blank C, Luz A, Bendigs S, Erdmann A, Wagner H, Heeg K: Superantigen and endotoxin synergize in the induction of lethal shock. Eur J Immunol 1997;27:825-833.
24. Chambrier C, Laville M, Rhzioual Berrada K, Odeon M, Bouletreau P, Beylot M: Insulin sensitivity of glucose and fat metabolism in severe sepsis. Clin Sci (Lond) 2000;99:321-328.